About Kythera

KYTHERA is a privately-held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic market.

The aesthetic market is characterized by an aging population, increasing discretionary income and an evolution of patient preference towards care that focuses on quality of life.

KYTHERA’s product discovery process is driven by:
  • The identification of new market opportunities in aesthetics.
  • A research-based exploration of underlying biology to address the market opportunity.
  • Where possible, identification of chemical matter with previous human exposure to modify the targeted biology.
  • An in-depth analysis of intellectual property for the emerging program.

KYTHERA applies a rigorous, no-compromise approach to pre-clinical, clinical, manufacturing and quality for all programs that progress from the early research stage.

KYTHERA’s development efforts are led by its management team with 100+ years of biotechnology experience combined with 20+ years of clinical and regulatory experience in the area of prescription aesthetic products.

KYTHERA’s efforts are supported by highly experienced board of directors and investors.